Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
10,871 total articles
BrainsWay Ltd. has announced a strategic minority-stake investment in Hopemark Health, a mental health clinic management services organization. The initial $1.5 million investment, with potential additional milestone-based funding, aims to enhance access to advanced interventional psychiatry treatments such as Deep Transcranial Magnetic Stimulation…
Streamex Corp. announced the distribution of its second monthly yield payment for GLDY, a gold-backed, yield-bearing tokenized security, reflecting successful deployment of gold reserves into an institutional gold leasing program yielding 3.5% annually. The company emphasizes continued scaling and secondary trading venue rollouts for GLDY.
NervGen Pharma Corp. reported Q1 2026 financial results highlighting completion of a successful FDA End-of-Phase 2 meeting aligning study parameters for RESTORE, a pivotal trial for NVG-291 in chronic tetraplegia. Site activations are underway, targeting study initiation in mid-2026. The company completed its Nasdaq uplisting, strengthened its lead…
An independent, NIMH-funded study of over 6,200 U.S. college students found that Amwell's SilverCloud digital behavioral health platform reduces the prevalence of mental disorders by up to 3.8% over two years. The proactive care model led to higher engagement rates than traditional behavioral health solutions and demonstrated potential economic sav…
urban-gro, Inc. (NASDAQ: UGRO), via its subsidiary Innovative Production Group (IPG), confirms full franchise lineup and new ownership groups for Lanka Premier League (LPL) Season 6 scheduled for July-August 2026. The firm gains exposure across the league's media, sponsorship, and activation economics. Newly named ownership includes U.S.-based inve…
Diana Shipping Inc., a leading dry bulk shipping company and largest shareholder of Genco Shipping & Trading Limited, cautions that Genco's current share price is artificially inflated due to Diana's $23.50 per share acquisition offer. Diana warns that without their offer, Genco's stock could fall to approximately $17.50 per share, reflecting a his…
IREN Limited, a NASDAQ-listed AI Cloud data center and GPU cluster provider, has acquired Awaken, a creative and media agency that has been its external marketing partner. Bringing Awaken's team in-house aims to strengthen IREN's brand awareness and marketing capabilities as it expands into new regions including North America, Europe, and APAC. Thi…
NRx Pharmaceuticals reported significant progress in Q1 2026 including anticipated FDA decision on preservative-free ketamine ANDA, initiation of commercial manufacturing at 1 million doses per month, FDA acceptance of NRX-101 IND for adjunct TMS therapy, expansion of interventional psychiatry clinics, and pending acquisition of assets targeting se…
Onfolio Holdings Inc., a Nasdaq-listed owner-operator of cash-generative online businesses, announced its Q1 2026 financial results. The company posted a decrease in revenue and gross profit compared to Q1 2025 but significantly improved operating margins through cost reductions and an AI-driven operating model. Onfolio secured a $100 million equit…
Can-Fite BioPharma and Vetbiolix published a peer-reviewed study demonstrating Piclidenoson significantly improves clinical signs of canine osteoarthritis with a favorable safety profile. This validates Piclidenoson’s potential as an oral disease-modifying therapy in a large veterinary market. The drug is under development by Vetbiolix through a li…
BeyondSpring Inc. announced a poster presentation at the 2026 ASCO Annual Meeting showcasing Study 303, a Phase 2 investigator-initiated trial investigating the efficacy and safety of a triple combination therapy of plinabulin, docetaxel, and pembrolizumab in metastatic non-small cell lung cancer (NSCLC) patients resistant to PD-1/PD-L1 inhibitors.…
INNEOVA Holdings Limited reported its fiscal year 2025 financial results, highlighting a 75% increase in operating cash flow to $4.4 million despite a slight revenue decline due to softer international demand. The company successfully integrated the acquired INNEOVA Engineering business and secured significant contracts including a multi-year overh…
Ashland Inc. announced the appointment of Bertrand Loy to its board of directors effective May 15, 2026. Loy brings extensive experience from the technology industry, particularly from his leadership roles at Entegris Inc. His addition supports Ashland's strategic objectives to expand, innovate, and pursue scalable growth globally. The board size w…
Orion Group Holdings, a specialty construction company, announced that its management will participate in two major investor conferences in May 2026. The company serves infrastructure, industrial, and building sectors through marine and concrete services across various North American and Caribbean regions.
GXO Logistics, the world's largest pure-play contract logistics provider listed on the NYSE, has been named one of the Best Places to Work in Spain for 2026 by Forbes, marking the sixth time it has received this recognition. The accolade underscores GXO's focus on employee development, training, diversity, and technological innovation, supported by…
Quantum Cyber N.V., a Nasdaq-listed autonomous defense technology company, announced its participation as an exhibitor at Special Operations Forces Week (SOF Week) 2026 in Tampa, Florida. The company will present its multi-mission autonomous UAV platform designed for surveillance, interdiction, and payload delivery, aligning with the needs of globa…
Regeneron Pharmaceuticals announces a strategic collaboration with Parabilis Medicines to develop new therapeutic candidates based on Parabilis' Helicon™ peptide platform combined with Regeneron's antibody technology. The deal includes a $125 million investment from Regeneron, potential milestone payments up to $2.2 billion, and aims to create inno…
Design Therapeutics announced encouraging clinical and biomarker results from its ongoing Phase 1/2 RESTORE-FA trial of DT-216P2, an investigational gene-targeted therapy for Friedreich Ataxia. The drug demonstrated dose-dependent increases in frataxin mRNA and protein levels, along with measurable clinical improvements in neurological function and…
Brady Corporation announced strong third quarter fiscal 2026 financial results with a 13.8% sales increase, 23% rise in adjusted diluted EPS to $1.50, and improved full-year adjusted EPS guidance. The company also entered into an agreement to acquire Honeywell's Productivity Solutions and Services business, expected to close in the second half of 2…
Ring Energy, Inc. announced participation in a fireside chat with Water Tower Research on May 20, 2026, where company executives will discuss the transition towards more horizontal development in their Permian Basin assets, recent capital markets activities enhancing financial flexibility, and strategies to improve free cash flow and balance sheet …
Castellum, Inc., a cybersecurity and technology company serving U.S. federal government clients, reminds stockholders of its 2026 Annual Meeting on May 19, 2026. Stockholders can attend in person or virtually and are encouraged to vote in advance. After the meeting, management will present and answer questions. The company emphasizes its commitment…
Genco Shipping & Trading Limited reaffirms confidence in its Comprehensive Value Strategy that has generated $310 million in dividends since 2021, driven significant fleet growth, and maintained industry-low leverage. The company reported a 358% increase in Q1 2026 net income alongside a 133% dividend increase year-over-year and projects continued …
Context Therapeutics amended its license agreement with BioAtla to acquire full economic rights to its CT-202 drug candidate, eliminating future milestone and royalty payments in exchange for upfront and deferred payments. CT-202, targeting Nectin-4 in solid tumors, is scheduled to enter Phase 1 clinical trials in Q3 2026, reflecting a strategic st…
Perspective Therapeutics, Inc. announced dosing of first patients in new cohorts of two ongoing Phase 1/2a clinical trials involving their radiopharmaceuticals [212Pb]VMT-α-NET for neuroendocrine tumors and [212Pb]PSV359 for solid tumors expressing fibroblast activation protein alpha (FAP-α). These trials aim to optimize dosing regimens and evaluat…
Sachem Capital Corp. and Industrial Realty Group announced a strategic combination where IRG will contribute 98 industrial assets to Sachem, creating IRG Realty Trust (IRGT) with an implied enterprise value of approximately $3.4 billion. The deal transforms Sachem from a subscale mortgage REIT to a top-10 publicly listed industrial REIT that focuse…
